**Core Concept**
The use of oral contraceptive pills (OCPs) is guided by the principle of balancing the benefits of contraception against the potential risks associated with their use. **Thrombogenicity** is a key concern, as OCPs can increase the risk of venous thromboembolism (VTE).

**Why the Correct Answer is Right**
Given the options are missing, a common absolute contraindication for prescribing OCPs in a young female of reproductive age would be a history of **pulmonary embolism** or **deep vein thrombosis**, as these conditions indicate a predisposition to thrombosis, which could be exacerbated by OCPs. The mechanism involves the **estrogen** component of OCPs, which can increase the synthesis of **clotting factors** and decrease the production of **anticoagulant proteins**.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific option provided, a common incorrect option might be "migraine without aura," which, while a precaution, is not typically an absolute contraindication.
**Option B:** Similarly, "hypertension" might be a precaution but not an absolute contraindication unless it's uncontrolled.
**Option C:** And "smoking" is a concern, particularly in women over 35, but not typically an absolute contraindication in a young female.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that any condition which significantly increases the risk of thrombosis (such as a history of VTE) is usually an absolute contraindication for the use of combined estrogen-progestin OCPs.

**Correct Answer:** D. Previous history of deep vein thrombosis or pulmonary embolism.